ResMed Inc (RMD)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Oct 23, 2026 | RIDER, MICHAEL J | Global General Counsel | ResMed Common Stock | Disposal | 400 | $255 |
| Oct 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Acquisition | 4,991 | $0 |
| Oct 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Acquisition | 4,991 | $146.34 |
| Oct 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Disposal | 4,991 | $226.33 |
| Sep 8, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Disposal | 4,991 | $222.44 |
| Sep 8, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Acquisition | 4,991 | $146.34 |
| Sep 8, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Disposal | 4,991 | $0 |
| Sep 8, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Acquisition | 4,991 | $0 |
| Sep 2, 2026 | FARRELL, PETER C | Director | ResMed Common Stock | Disposal | 970 | $234.73 |
| Aug 14, 2026 | LEONG, JUSTIN | Chief Product Officer | ResMed Common Stock | Acquisition | 6,461 | $0 |
| Aug 14, 2026 | BLOOMER, AARON | Chief Financial Officer | ResMed Common Stock | Acquisition | 9,072 | $0 |
| Aug 14, 2026 | RIDER, MICHAEL J | Global General Counsel | ResMed Common Stock | Acquisition | 3,230 | $0 |
| Aug 14, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Acquisition | 13,547 | $0 |
| Aug 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Disposal | 4,991 | $0 |
| Aug 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Acquisition | 4,991 | $146.34 |
| Aug 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Disposal | 4,991 | $205.69 |
| Aug 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Acquisition | 4,991 | $0 |
| Aug 5, 2026 | FARRELL, PETER C | Director | ResMed Common Stock | Disposal | 8,000 | $225 |
| Jul 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Disposal | 4,991 | $0 |
| Jul 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Disposal | 4,991 | $218.55 |
| Jul 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Acquisition | 4,991 | $146.34 |
| Jul 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Acquisition | 4,991 | $0 |
| Jun 8, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Disposal | 4,991 | $0 |
| Jun 8, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Acquisition | 4,991 | $146.34 |
| Jun 8, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Disposal | 4,991 | $193.96 |
| Jun 8, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Acquisition | 4,991 | $0 |
| Jun 1, 2026 | RIDER, MICHAEL J | Global General Counsel | ResMed Common Stock | Disposal | 268.74 | $190.57 |
| May 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Disposal | 4,991 | $0 |
| May 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Acquisition | 4,991 | $146.34 |
| May 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Disposal | 4,991 | $207.82 |
| May 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Acquisition | 4,991 | $0 |
| Apr 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Acquisition | 4,991 | $146.34 |
| Apr 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Disposal | 4,991 | $225.50 |
| Apr 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Disposal | 4,991 | $0 |
| Apr 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Acquisition | 4,991 | $0 |
| Apr 1, 2026 | SANDERCOCK, BRETT | Chief Financial Officer | ResMed Common Stock | Disposal | 1,000 | $224.31 |
| Apr 1, 2026 | FARRELL, PETER C | Director | ResMed Common Stock | Disposal | 2,000 | $225 |
| Mar 9, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Disposal | 4,991 | $251.03 |
| Mar 9, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Acquisition | 4,991 | $146.34 |
| Mar 9, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Disposal | 4,991 | $0 |
| Mar 9, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Acquisition | 4,991 | $0 |
| Mar 4, 2026 | FARRELL, PETER C | Director | ResMed Common Stock | Disposal | 2,000 | $260.22 |
| Mar 2, 2026 | SANDERCOCK, BRETT | Chief Financial Officer | ResMed Common Stock | Disposal | 1,000 | $254.30 |
| Feb 9, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Disposal | 4,991 | $0 |
| Feb 9, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Disposal | 4,991 | $273.78 |
| Feb 9, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Acquisition | 4,991 | $146.34 |
| Feb 9, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Acquisition | 4,991 | $0 |
| Feb 4, 2026 | RIDER, MICHAEL J | Global General Counsel | ResMed Common Stock | Disposal | 50 | $260 |
| Feb 4, 2026 | FARRELL, PETER C | Director | ResMed Common Stock | Disposal | 2,000 | $251.31 |
| Feb 2, 2026 | SANDERCOCK, BRETT | Chief Financial Officer | ResMed Common Stock | Disposal | 1,000 | $257.03 |
| Jan 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Disposal | 4,991 | $0 |
| Jan 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Acquisition | 4,991 | $146.34 |
| Jan 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Disposal | 4,991 | $248.46 |
| Jan 7, 2026 | FARRELL, PETER C | Director | ResMed Common Stock | Disposal | 2,000 | $248.83 |
| Jan 7, 2026 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Acquisition | 4,991 | $0 |
| Jan 2, 2026 | RIDER, MICHAEL J | Global General Counsel | ResMed Common Stock | Disposal | 50 | $241.75 |
| Jan 2, 2026 | SANDERCOCK, BRETT | Chief Financial Officer | ResMed Common Stock | Disposal | 1,000 | $241.75 |
| Dec 8, 2025 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Disposal | 4,991 | $251.41 |
| Dec 8, 2025 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Disposal | 4,991 | $0 |
| Dec 8, 2025 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Acquisition | 4,991 | $146.34 |
| Dec 8, 2025 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Acquisition | 4,991 | $0 |
| Dec 3, 2025 | FARRELL, PETER C | Director | ResMed Common Stock | Disposal | 2,000 | $251.47 |
| Dec 1, 2025 | SANDERCOCK, BRETT | Chief Financial Officer | ResMed Common Stock | Disposal | 1,000 | $244.16 |
| Dec 1, 2025 | RIDER, MICHAEL J | Global General Counsel | ResMed Common Stock | Disposal | 50 | $244.16 |
| Nov 25, 2025 | DE, WITTE JAN | Director | ReMed Common Stock | Disposal | 2,055 | $255 |
| Nov 24, 2025 | FARRELL, PETER C | Director | ResMed Common Stock Options | Acquisition | 1,331 | $250.52 |
| Nov 24, 2025 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock Options | Acquisition | 33,288 | $250.52 |
| Nov 24, 2025 | MOWAD-NASSAR, NICOLE | Director | ResMed Common Stock Options | Acquisition | 1,331 | $250.52 |
| Nov 20, 2025 | MOWAD-NASSAR, NICOLE | Director | ResMed Common Stock | Acquisition | 536 | $0 |
| Nov 20, 2025 | FARRELL, PETER C | Director | ResMed Common Stock | Acquisition | 536 | $0 |
| Nov 20, 2025 | TAYLOR, RONALD R | Director | ResMed Common Stock | Acquisition | 1,073 | $0 |
| Nov 20, 2025 | DELOREFICE, CHRISTOPHER | Director | ResMed Common Stock | Acquisition | 1,073 | $0 |
| Nov 20, 2025 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Acquisition | 13,551 | $0 |
| Nov 20, 2025 | FARRELL, MICHAEL J. | Director, Chairman and CEO | ResMed Common Stock | Disposal | 7,297 | $0 |
| Nov 20, 2025 | DE, WITTE JAN | Director | ReMed Common Stock | Acquisition | 1,073 | $0 |
| Nov 20, 2025 | TAN, DESNEY | Director | ResMed Common Stock | Acquisition | 1,073 | $0 |
| Nov 20, 2025 | SANDERCOCK, BRETT | Chief Financial Officer | ResMed Common Stock | Acquisition | 2,710 | $0 |
| Nov 20, 2025 | GILL, HARJIT | Director | ResMed Common Stock | Acquisition | 1,073 | $0 |
| Nov 20, 2025 | HERNANDEZ, JOHN | Director | ResMed Common Stock | Acquisition | 1,073 | $0 |
| Nov 20, 2025 | LEONG, JUSTIN | Chief Product Officer | ReMed Common Stock | Acquisition | 1,848 | $0 |
| Nov 20, 2025 | BURT, CAROL | Director | ResMed Common Stock | Acquisition | 1,073 | $0 |
| Nov 20, 2025 | DREXLER, KAREN | Director | ResMed Common Stock | Acquisition | 1,073 | $0 |
| Nov 14, 2025 | FARRELL, PETER C | Director | ResMed Common Stock Options | Disposal | 11,442 | $0 |
| Nov 14, 2025 | FARRELL, PETER C | Director | ResMed Common Stock | Disposal | 7,314 | $244.46 |
| Nov 14, 2025 | FARRELL, PETER C | Director | ResMed Common Stock | Acquisition | 11,442 | $101.64 |
| Nov 14, 2025 | FARRELL, PETER C | Director | ResMed Common Stock Options | Acquisition | 11,442 | $0 |
| Nov 12, 2025 | FARRELL, PETER C | Director | ResMed Common Stock | Disposal | 2,000 | $252.05 |